Carlos Rodriguez-Galindo, MD
Carlos Rodriguez-Galindo, MD

Carlos Rodriguez-Galindo, MD

Member, St. Jude Faculty

  • Executive Vice President
  • Chair, Department of Global Pediatric Medicine
  • Director, International Outreach Program
  • Associate Director, Outreach, Comprehensive Cancer Center

Departments

Education

MD – Autonomous University of Barcelona, Spain

Honors & Awards

  • 2014  Innovation Award, Dana-Farber Cancer Institute
  • 2010  Holcombe E. Grier Award for Excellence in Teaching, Dana-Farber/Children’s Cancer Center, Harvard Medical School
  • 2004-2006  Translational Research Award, Children’s Oncology Group
  • 2004  Outstanding Clinical of the Year, St. Jude Children’s Research Hospital
  • 2001  Imminent Scientist and Outstanding Scholar of the Year, International Research Promotion Council (Asia-Pacific Chapter)
  • 2000-2001 Teaching Award, Pediatric and Medicine/Pediatric House Staff, University of Tennessee
  • 1998-1999 Teaching Award, Pediatric and Medicine/Pediatric House Staff, University of Tennessee

Research Interests

  • Global medicine
  • Pediatric solid tumors

Selected Publications

Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, Israels T, Jeha S, Harif M, Sullivan MJ, Quah TC, Patte C, Pui CH, Barr R, Gross T. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. J Clin Oncol Sep 20;33(27):3065-73, 2015.  

Monsereenusorn C, Rodriguez-Galindo C. Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am  Oct;29(5):853-73, 2015.  

Truong B, Green AL, Friedrich P, Ribeiro KB, Rodriguez-Galindo C. Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma. JAMA Pediatr Dec 1;169(12):1096-1104, 2015.  

Brunetto AL, Castillo LA, Petrilli AS, Macedo CD, Boldrini E, Costa C, Almeida MT, Kirst D, Rodriguez-Galindo C, Pereira WV, Watanabe FM, Pizza M, Benites E, Morais V, Gadelha A, Nakasato A, Abujamra AL, Gregianin LJ; Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors - EWING1 and the Brazilian Society of Pediatric Oncology - SOBOPE. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. Pediatr Blood Cancer Oct;62(10):1747-1753, 2015.

Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Clin Transl Oncol Aug 7, 2015.

Archer NM, Amorim RP, Naves R, Hettmer S, Diller LR, Ribeiro KB, Rodriguez-Galindo C. An increased risk of second malignant neoplasms after rhabdomyosarcoma: Population-based evidence for a cancer predisposition syndrome? Pediatr Blood Cancer Jul 2, 2015.

Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson RK, Boggs K, Yergeau D, Cheng J, Mulder HL, Manne J, Jenkins J, Mastellaro MJ, Figueiredo BC, Dyer MA, Pappo A, Zhang J, Downing JR, Ribeiro RC, Zambetti GP. Genomic landscape of paediatric adrenocortical tumours. Nat Commun Mar;6;6:6302, 2015.

Ribeiro KB, Degar B, Antoneli CB, Rollins B, Rodriguez-Galindo C. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer Jan 13, 2005.

Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, Helman E, Taylor-Weiner A, McKenna A, DeLuca DS, Lawrence MS, Ambrogio L, Sougnez C, Sivachenko A, Walensky LD, Wagle N, Mora J, de Torres C, Lavarino C, Dos Santos Aguiar S, Yunes JA, Brandalise SR, Mercado-Celis GE, Melendez-Zajgla J, Cárdenas-Cardós R, Velasco-Hidalgo L, Roberts CW, Garraway LA, Rodriguez-Galindo C, Gabriel SB, Lander ES, Golub TR, Orkin SH, Getz G, Janeway KA. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci USA 111:E5564-73, 2014.

Frazier AL, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray MJ, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J Clin Oncol 33:195-201, 2015.

Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA, Huh WW. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer Nov 25, 2014.

Raciborska A, Bilska K, Filipp E, Drabko K, Rogowska E, Chaber R, Pogorzała M, Połczyńska K, Adrianowska N, Rodriguez-Galindo C, Maciejewski T. Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr Blood Cancer Nov 15, 2014.

Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Sunol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J, Stegmaier K. The Genomic Landscape of Pediatric Ewing Sarcoma. Cancer Discov 4:1326-41, 2014.

Raciborska A, Bilska K, Drabko K, Chaber R, Sobol G, Pogorzała M, Wyrobek E, Połczyńska K, Rogowska E, Rodriguez-Galindo C, Wożniak W. Validation of a multi-modal treatment protocol for Ewing sarcoma-A report from the polish pediatric oncology group. Pediatr Blood Cancer 61:2170-4, 2014.

Willard VW, Qaddoumi I, Chen S, Zhang H, Brennan R, Rodriguez-Galindo C, Wilson MW, Phipps S. Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation. J Clin Oncol Sep 1;32(25):2788-93, 2014.

Pugh TJ, Yu W, Yang J, Field AL, Ambrogio L, Carter SL, Cibulskis K, Giannikopoulos P, Kiezun A, Kim J, McKenna A, Nickerson E, Getz G, Hoffher S, Messinger YH, Dehner LP, Roberts CW, Rodriguez-Galindo C, Williams GM, Rossi CT, Meyerson M, Hill DA. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene 33:5295-302, 2014.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL. Adolescents and young adults with a “rare” cancer: Getting past semantics to optimal care fo patients with germ cell tumors. Oncologist 19:689-92, 2014.

Vergamini LB, Frazier AL, Abrantes FL, Ribeiro KB, Rodriguez-Galindo C. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents and young adults: A population-based study. J Pediatr 164:1481-5, 2014.

Sullivan EM, Wilson MW, Billups CA, Wu J, Merchant TE, Brennan RC, Haik BG, Shulkin B, Free TM, Given V, Rodriguez-Galindo C, Qaddoumi I. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation. J Pediatr Hematol Oncol 36:e335-40, 2014.

Hettmer S, Teot LA, Kozakewich H, Werger AM, Davies KJ, Fletcher CD, Grier HE, Rodriguez-Galindo C, Wagers AJ. Myogenic tumors in nevoid basal cell carcinoma syndrome. J Pediatr Hematol Oncol Feb 10, 2014. (Epub ahead of print)

Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer 120:1068-75, 2014.

Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL. Surveillance After Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report From the Children's Oncology Group. J Clin Oncol Feb 10;32(5):465-70, 2014.

Barr RD, Antillón Klussmann F, Baez F, Bonilla M, Moreno B, Navarrete M, Nieves R, Peña A, Conter V, De Alarcón P, Howard SC, Ribeiro RC, Rodriguez-Galindo C, Valsecchi MG, Biondi A, Velez G, Tognoni G, Cavalli F, Masera G. Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in pediatric oncology. Pediatr Blood Cancer 61:345-54, 2014.

Senerchia AA, Ribeiro KB, Rodriguez-Galindo C. Trends in incidence of primary cutaneous malignancies in children, adolescents and young adults: a population-based study. Pediatr Blood Cancer 61:211-6, 2014.

Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, Munzenrider JE, Grabowski E, Rodriguez-Galindo C, Yock TI, Tarbell NJ, Marcus KJ, Mukai S, Macdonald SM. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton therapy. Cancer 120:126-33, 2014.

Friedrich P, Ortiz R, Fuentes S, Gamboa Y, Ah Chu-Sanchez MS, Arambú IC, Montero M, Báez F, Rodríguez-Galindo C, Antillón-Klussmann F. Barriers to effective treatment of pediatric solid tumors in the middle-income countries: Can we make sense of the spectrum of nonbiologic factors that influence outcomes? Cancer 120:112-25, 2014.

Last update: December 2015